4//SEC Filing
WERNER HAROLD R 4
Accession 0000899243-16-013608
CIK 0001445283other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 6:45 PM ET
Size
29.2 KB
Accession
0000899243-16-013608
Insider Transaction Report
Form 4
Mirabelli Christopher
Director10% Owner
Transactions
- Other
Common Stock Warrant (Right to Buy)
2016-02-17+14,800→ 14,800 total(indirect: See Footnote)Exercise: $10.81From: 2008-07-08Exp: 2018-07-08→ Common Stock (14,800 underlying) - Conversion
Series B Convertible Redeemable Preferred Stock
2016-02-17−2,319,750→ 0 total(indirect: See Footnote)→ Common Stock (214,588 underlying) - Other
Series A Convertible Preferred Warrant (Right to Buy)
2016-02-17−160,000→ 0 total(indirect: See Footnote)Exercise: $1.00From: 2008-07-08Exp: 2018-07-08→ Series A Preferred Stock (160,000 underlying) - Conversion
Common Stock
2016-02-17+1,774,295→ 1,774,295 total(indirect: See Footnote) - Purchase
Common Stock
2016-02-17$8.00/sh+375,000$3,000,000→ 2,149,295 total(indirect: See Footnote) - Conversion
Series A Convertible Redeemable Preferred Stock
2016-02-17−11,600,000→ 0 total(indirect: See Footnote)→ Common Stock (1,559,707 underlying)
HealthCare Ventures VIII, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2016-02-17+1,774,295→ 1,774,295 total(indirect: See Footnote) - Purchase
Common Stock
2016-02-17$8.00/sh+375,000$3,000,000→ 2,149,295 total(indirect: See Footnote) - Conversion
Series A Convertible Redeemable Preferred Stock
2016-02-17−11,600,000→ 0 total(indirect: See Footnote)→ Common Stock (1,559,707 underlying) - Conversion
Series B Convertible Redeemable Preferred Stock
2016-02-17−2,319,750→ 0 total(indirect: See Footnote)→ Common Stock (214,588 underlying) - Other
Series A Convertible Preferred Warrant (Right to Buy)
2016-02-17−160,000→ 0 total(indirect: See Footnote)Exercise: $1.00From: 2008-07-08Exp: 2018-07-08→ Series A Preferred Stock (160,000 underlying) - Other
Common Stock Warrant (Right to Buy)
2016-02-17+14,800→ 14,800 total(indirect: See Footnote)Exercise: $10.81From: 2008-07-08Exp: 2018-07-08→ Common Stock (14,800 underlying)
CAVANAUGH JAMES H
10% Owner
Transactions
- Conversion
Common Stock
2016-02-17+1,774,295→ 1,774,295 total(indirect: See Footnote) - Purchase
Common Stock
2016-02-17$8.00/sh+375,000$3,000,000→ 2,149,295 total(indirect: See Footnote) - Conversion
Series A Convertible Redeemable Preferred Stock
2016-02-17−11,600,000→ 0 total(indirect: See Footnote)→ Common Stock (1,559,707 underlying) - Conversion
Series B Convertible Redeemable Preferred Stock
2016-02-17−2,319,750→ 0 total(indirect: See Footnote)→ Common Stock (214,588 underlying) - Other
Series A Convertible Preferred Warrant (Right to Buy)
2016-02-17−160,000→ 0 total(indirect: See Footnote)Exercise: $1.00From: 2008-07-08Exp: 2018-07-08→ Series A Preferred Stock (160,000 underlying) - Other
Common Stock Warrant (Right to Buy)
2016-02-17+14,800→ 14,800 total(indirect: See Footnote)Exercise: $10.81From: 2008-07-08Exp: 2018-07-08→ Common Stock (14,800 underlying)
HealthCare Partners VIII, LLC
10% Owner
Transactions
- Conversion
Common Stock
2016-02-17+1,774,295→ 1,774,295 total(indirect: See Footnote) - Purchase
Common Stock
2016-02-17$8.00/sh+375,000$3,000,000→ 2,149,295 total(indirect: See Footnote) - Other
Common Stock Warrant (Right to Buy)
2016-02-17+14,800→ 14,800 total(indirect: See Footnote)Exercise: $10.81From: 2008-07-08Exp: 2018-07-08→ Common Stock (14,800 underlying) - Conversion
Series A Convertible Redeemable Preferred Stock
2016-02-17−11,600,000→ 0 total(indirect: See Footnote)→ Common Stock (1,559,707 underlying) - Conversion
Series B Convertible Redeemable Preferred Stock
2016-02-17−2,319,750→ 0 total(indirect: See Footnote)→ Common Stock (214,588 underlying) - Other
Series A Convertible Preferred Warrant (Right to Buy)
2016-02-17−160,000→ 0 total(indirect: See Footnote)Exercise: $1.00From: 2008-07-08Exp: 2018-07-08→ Series A Preferred Stock (160,000 underlying)
LAWLOR AUGUSTINE
10% Owner
Transactions
- Other
Common Stock Warrant (Right to Buy)
2016-02-17+14,800→ 14,800 total(indirect: See Footnote)Exercise: $10.81From: 2008-07-08Exp: 2018-07-08→ Common Stock (14,800 underlying) - Conversion
Common Stock
2016-02-17+1,774,295→ 1,774,295 total(indirect: See Footnote) - Conversion
Series A Convertible Redeemable Preferred Stock
2016-02-17−11,600,000→ 0 total(indirect: See Footnote)→ Common Stock (1,559,707 underlying) - Other
Series A Convertible Preferred Warrant (Right to Buy)
2016-02-17−160,000→ 0 total(indirect: See Footnote)Exercise: $1.00From: 2008-07-08Exp: 2018-07-08→ Series A Preferred Stock (160,000 underlying) - Purchase
Common Stock
2016-02-17$8.00/sh+375,000$3,000,000→ 2,149,295 total(indirect: See Footnote) - Conversion
Series B Convertible Redeemable Preferred Stock
2016-02-17−2,319,750→ 0 total(indirect: See Footnote)→ Common Stock (214,588 underlying)
LITTLECHILD JOHN W
10% Owner
Transactions
- Conversion
Common Stock
2016-02-17+1,774,295→ 1,774,295 total(indirect: See Footnote) - Purchase
Common Stock
2016-02-17$8.00/sh+375,000$3,000,000→ 2,149,295 total(indirect: See Footnote) - Conversion
Series A Convertible Redeemable Preferred Stock
2016-02-17−11,600,000→ 0 total(indirect: See Footnote)→ Common Stock (1,559,707 underlying) - Conversion
Series B Convertible Redeemable Preferred Stock
2016-02-17−2,319,750→ 0 total(indirect: See Footnote)→ Common Stock (214,588 underlying) - Other
Series A Convertible Preferred Warrant (Right to Buy)
2016-02-17−160,000→ 0 total(indirect: See Footnote)Exercise: $1.00From: 2008-07-08Exp: 2018-07-08→ Series A Preferred Stock (160,000 underlying) - Other
Common Stock Warrant (Right to Buy)
2016-02-17+14,800→ 14,800 total(indirect: See Footnote)Exercise: $10.81From: 2008-07-08Exp: 2018-07-08→ Common Stock (14,800 underlying)
WERNER HAROLD R
10% Owner
Transactions
- Conversion
Common Stock
2016-02-17+1,774,295→ 1,774,295 total(indirect: See Footnote) - Conversion
Series A Convertible Redeemable Preferred Stock
2016-02-17−11,600,000→ 0 total(indirect: See Footnote)→ Common Stock (1,559,707 underlying) - Purchase
Common Stock
2016-02-17$8.00/sh+375,000$3,000,000→ 2,149,295 total(indirect: See Footnote) - Conversion
Series B Convertible Redeemable Preferred Stock
2016-02-17−2,319,750→ 0 total(indirect: See Footnote)→ Common Stock (214,588 underlying) - Other
Series A Convertible Preferred Warrant (Right to Buy)
2016-02-17−160,000→ 0 total(indirect: See Footnote)Exercise: $1.00From: 2008-07-08Exp: 2018-07-08→ Series A Preferred Stock (160,000 underlying) - Other
Common Stock Warrant (Right to Buy)
2016-02-17+14,800→ 14,800 total(indirect: See Footnote)Exercise: $10.81From: 2008-07-08Exp: 2018-07-08→ Common Stock (14,800 underlying)
HealthCare Partners VIII, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2016-02-17+1,774,295→ 1,774,295 total(indirect: See Footnote) - Purchase
Common Stock
2016-02-17$8.00/sh+375,000$3,000,000→ 2,149,295 total(indirect: See Footnote) - Conversion
Series A Convertible Redeemable Preferred Stock
2016-02-17−11,600,000→ 0 total(indirect: See Footnote)→ Common Stock (1,559,707 underlying) - Conversion
Series B Convertible Redeemable Preferred Stock
2016-02-17−2,319,750→ 0 total(indirect: See Footnote)→ Common Stock (214,588 underlying) - Other
Series A Convertible Preferred Warrant (Right to Buy)
2016-02-17−160,000→ 0 total(indirect: See Footnote)Exercise: $1.00From: 2008-07-08Exp: 2018-07-08→ Series A Preferred Stock (160,000 underlying) - Other
Common Stock Warrant (Right to Buy)
2016-02-17+14,800→ 14,800 total(indirect: See Footnote)Exercise: $10.81From: 2008-07-08Exp: 2018-07-08→ Common Stock (14,800 underlying)
Footnotes (6)
- [F1]This transaction represents the total number of shares of Common Stock of the Issuer (the "Issuer Common Stock") received upon the conversion of the Issuer's Series A Convertible Redeemable Preferred Stock (the "Series A Shares"), the payment of accrued dividends on the Series A Shares and the conversion of the Issuer's Series B Convertible Redeemable Preferred Stock ( collectively, the "Preferred Shares").
- [F2]The securities are held of record by HealthCare Ventures VIII, L.P. ("HCVVIII"). HealthCare Partners VIII, L.P. ("HCPVIII") is the General Partner of HCVVIII and HealthCare Partners VIII, LLC (the "LLC") is the General Partner of HCPVIII. Each of James Cavanaugh, Harold Werner, John Littlechild, Christopher Mirabelli and Augustine Lawlor are the managing directors of the LLC and exercise shared voting and investment power with respect to the shares owned by HCVVIII. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuniary interest therein. Dr. Mirabelli is also a director of the issuer.
- [F3]These securities were purchased in the initial public offering of the Issuer.
- [F4]The Preferred Shares automatically converted into Issuer Common Stock on a 10.8102-to-1 basis upon the closing of the initial public offering of the Issuer without payment or further consideration. The Preferred Shares were convertible at any time at the election of the Reporting Person and had no expiration date.
- [F5]These securities include shares of Issuer Common Stock received as payment for accrued dividends on the Series A Shares.
- [F6]This transaction represents a deemed disposition of warrants to purchase Series A Shares and a deemed acquisition of warrants to purchase shares of Issuer Common Stock on a 10.8102-to-1 basis, which occurred automatically upon the closing of the initial public offering of the Issuer without payment or further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants.
Documents
Issuer
PROTEOSTASIS THERAPEUTICS, INC.
CIK 0001445283
Entity typeother
Related Parties
1- filerCIK 0001013603
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 6:45 PM ET
- Size
- 29.2 KB